Skip to main content
. 2021 Sep 30;29(2):1053–1060. doi: 10.1016/j.sjbs.2021.09.067

Table 1.

Serum glucose, insulin, C-peptide, HbA1c, AGEs and HO-1 levels.

Control Diabetic (D) D + AD-MSCs D + BM-MSCs
Glucose(mg/ 100 ml) 93.91 ± 4.42 405.40 ± 16.46 a 96.75 ± 5.70b 150.50 ± 5.22abc
Insulin (µ I U/ml) 17.15 ± 0.66 8.02 ± 0.33a 16.90 ± 0.34b 13.32 ± 0.57abc
C-peptide (ng/ml) 0.84 ± 0.03 0.30 ± 0.03a 0.81 ± 0.01b 0.75 ± 0.02abc
HbA1c (%) 2.95 ± 0.11 5.90 ± 0.20a 2.93 ± 0.14b 3.49 ± 0.10abc
AGEs (AU/mg protein) 2.80 ± 0.11 8.46 ± 0.35a 3.00 ± 0.16b 4.12 ± 0.12abc
HO-1 (P mol/mg) 260.00 ± 13.53 87.00 ± 3.60 a 264.66 ± 8.12b 218.00 ± 9.04abc

Values expressed as mean ± SEM (n = 6). a, b and c are Significant differences (P ≤ 0.05) comparing to control, diabetic and diabetic AD-MSCs treated groups respectively.